Clinical Trials Browser

OTHER × Prostatic Neoplasms × ibrutinib × Clear all

NCT02643667 2025-01-08

Ibrutinib as Neoadjuvant Therapy in Localized Prostate Cancer

Phase 2 Completed

27 enrolled 11 charts

Prostatic Neoplasms